Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1.
Mitchell
C D
CD
Department of Pediatrics, University of Miami School of Medicine, FL.
Erlich
S S
SS
Mastrucci
M T
MT
Hutto
S C
SC
Parks
W P
WP
Scott
G B
GB
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000635:transmission; D000818:Animals; D002493:Central Nervous System Diseases / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D005192:Family Health; D005260:Female; D015497:HIV-1; D006801:Humans; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014122:Toxoplasma / Q000302:isolation & purification; D014125:Toxoplasmosis, Congenital / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000635:transmission
D013411:Sulfadiazine; D011739:Pyrimethamine